This post was originally published on this siteWarren Buffett is about as different from the stereotypical Robinhood investor as you can get. Having just turned 90 years old, he’s very

This post was originally published on this siteOne stock appears to be the clear winner in a matchup between these big coronavirus-focused healthcare companies. Keith Speights. (TMFFishBiz). Aug

This post was originally published on this siteAny time is a great time to buy strong dividend stocks. They literally pay you to own them. Over the long run, you can amass tremendous returns by

This post was originally published on this siteAurora Cannabis (NYSE:ACB) and Canopy Growth (NYSE:CGC) have some bragging rights. They’re two of the biggest Canadian cannabis producers.

This post was originally published on this siteEither company could win the race to develop a COVID-19 vaccine, but one has an easier path to victory. Keith Speights. (TMFFishBiz). Aug 22, 2020

This post was originally published on this siteNovavax (NASDAQ:NVAX) stock is up around 3,500% so far this year. And that’s after a significant recent decline. Earlier this month, shares of

This post was originally published on this siteRotten, no good, horrible, abysmal! Take your pick of adjectives to describe how Myriad Genetics (NASDAQ:MYGN) has performed so far in 2020. Over

This post was originally published on this siteThere were plenty of questions earlier this year about how the COVID-19 pandemic might impact ResMed (NYSE:RMD). It’s fair to say that most of

This post was originally published on this siteJazz Pharmaceuticals (NASDAQ:JAZZ) hasn’t given investors much good news so far in 2020. The drugmaker’s first-quarter results announced

This post was originally published on this siteGilead Sciences (NASDAQ:GILD) beat Wall Street estimates when the big biotech announced its first-quarter results in late April. But the streak